References
- Baringer RJ, Swoveland P (1973): Recovery of herpes-simplex virus from human trigeminal ganglions. New Engl J Med 288: 648–650.
- Carter SK, Livingston RB (1976): Plant products in cancer chemotherapy. Cancer Treat Rep 60: 1141–1156.
- Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC (2002): Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res 55: 53–62.
- Coen DM (1994): Acyclovir-resistant, pathogenic her-pesviruses. Trends Microbiol 2: 481–485.
- Felser J, Kichington PR, Inchauspe G, Straus SE, Ostrove JM (1988): Cell line containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein com-plement ICP4 mutant of herpes simplex virus type 1. J Virol 62: 2076–2082.
- Gius D, Laimins LA (1989): Activation of human papillo-mavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and phorbol ester. J Virol 63: 555–563.
- Glatthaar-Saalmuller B, Sacher F, Esperester A (2001): Antivi-ral activity of an extract derived from roots of Eleuthero-coccus senticosus Antiviral Res 50: 223–228.
- Kurokawa M, Ochi H, Nagasaka K, Neki M, Xu H, Kadota S, Sutardjo S, Matsumoto T, Namba T, Shiraki K (1993): Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antivi-ral Res 22: 175–188.
- Logan WS, Tindall JP, Elson ML (1971): Chronic cutaneous herpes simplex. Arch. Dermatol 103: 606–614.
- Mann SL, Meyers JD, Holmes KL, Corey L (1984): Prevalence and incidence of herpes infections among homosexually active men. J Infect Dis 149: 1026–1027.
- Marsoni S, Wittes R (1984): Clinical development of anticancer agents-a National Cancer Institute perspective. Cancer Treat Rep 68: 77–85.
- Ostrove JM, Leonard J, Weck KE, Radson AB, Gendelman HE (1987): Activation of the human immunodeficiency virus by herpes simplex virus type 1. J Virol 61: 3726–3732.
- Pass RF, Long WK, Whitley RJ, Soong SJ, Diethelm AG, Reynolds DW, Alford CA Jr (1978): Productive infection with cytomegalovirus and herpes simplex virus in renal transparent recipients: role of source kidney. J Infect Dis 137: 556–563.
- Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, Clercq ED (1988): Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Meth 20: 309–321.
- Roizman B, Sears AE (1996): Herpes simplex virus and their replication. In: Fileds BN, Knipe DM, Howley PM, eds., Virology, Philadelphia, Lippincott-Raven Publishers, Publishers pp. 2231–2295.
- Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tiemey S, Nofziger TH, Currens MJ, Seniff D, Boyd MR (1998): Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827–4833.
- Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH, Boyd MR (1989): New soluble-formazan assay for HIV-1 cyto-pathic effects: Application to high-flux screening of syn-thetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81: 577–586.